News + Filings Transactions
|
Kreis Leslie W.
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
12/12/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 9.2k | $2.48 | $22.8k | See footnote | 12/12/2022 |
12/12/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 57.1k | $2.48 | $141.4k | See footnote | 12/12/2022 |
12/12/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 8.7k | $2.48 | $21.7k | See footnote | 12/12/2022 |
11/28/2022 | COGNITION THERAPEUTICS INC | CGTX | Purchase | Common Stock | 2k | $2.65 | $5.2k | By Bios Fund III NT, LP | 11/28/2022 |
11/28/2022 | COGNITION THERAPEUTICS INC | CGTX | Purchase | Common Stock | 12.2k | $2.65 | $32.4k | By Bios Fund III QP, LP | 11/28/2022 |
11/28/2022 | COGNITION THERAPEUTICS INC | CGTX | Purchase | Common Stock | 1.9k | $2.65 | $5k | By Bios Fund III, LP | 11/28/2022 |
11/16/2022 | COGNITION THERAPEUTICS INC | CGTX | Purchase | Common Stock | 8.7k | $1.40 | $12.2k | By Bios Fund III NT, LP | 11/16/2022 |
11/16/2022 | COGNITION THERAPEUTICS INC | CGTX | Purchase | Common Stock | 54k | $1.40 | $75.6k | By Bios Fund III QP, LP | 11/16/2022 |
11/16/2022 | COGNITION THERAPEUTICS INC | CGTX | Purchase | Common Stock | 8.3k | $1.40 | $11.6k | Bios Fund III, LP | 11/16/2022 |
11/15/2022 | COGNITION THERAPEUTICS INC | CGTX | Purchase | Common Stock | 184.3k | $1.20 | $221.1k | By Bios Fund III NT, LP | 11/15/2022 |
11/15/2022 | COGNITION THERAPEUTICS INC | CGTX | Purchase | Common Stock | 1.1M | $1.20 | $1.4M | By Bios Fund III QP, LP | 11/15/2022 |
11/15/2022 | COGNITION THERAPEUTICS INC | CGTX | Purchase | Common Stock | 174.7k | $1.20 | $209.6k | Bios Fund III, LP | 11/15/2022 |
09/28/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 3.1k | $2.02 | $6.2k | See footnote | 09/28/2022 |
09/28/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 19k | $2.02 | $38.4k | See footnote | 09/28/2022 |
09/28/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 2.9k | $2.02 | $5.9k | See footnote | 09/28/2022 |
09/02/2022 | Lantern Pharma Inc. | LTRN | Sale | Common Stock | 5.2k | $5.20 | $26.9k | By BP Directors,LP | 09/02/2022 |
09/02/2022 | Lantern Pharma Inc. | LTRN | Sale | Common Stock | 1.3k | $5.20 | $6.6k | By BP Directors,LP | 09/02/2022 |
09/02/2022 | Lantern Pharma Inc. | LTRN | Exercise (in-the-money or at-the-money) | Stock Option | 26.1k | $1.03 | $26.9k | By BP Directors,LP | 09/02/2022 |
09/02/2022 | Lantern Pharma Inc. | LTRN | Exercise (in-the-money or at-the-money) | Stock Option | 6.4k | $1.03 | $6.6k | By BP Directors,LP | 09/02/2022 |
08/29/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 4.7k | $2.02 | $9.4k | See footnote | 08/26/2022 |
08/29/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 4.9k | $2.02 | $9.9k | See footnote | 08/26/2022 |
08/29/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 30.4k | $2.02 | $61.5k | See footnote | 08/26/2022 |
08/26/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 1.3k | $2.01 | $2.6k | See footnote | 08/26/2022 |
08/26/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 8.5k | $2.01 | $17.1k | See footnote | 08/26/2022 |
08/26/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 1.4k | $2.01 | $2.8k | See footnote | 08/26/2022 |
08/17/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 6.1k | $1.93 | $11.9k | See footnote | 08/17/2022 |
08/17/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 38k | $1.93 | $73.4k | See footnote | 08/17/2022 |
08/17/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 5.8k | $1.93 | $11.2k | See footnote | 08/17/2022 |
08/16/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 217.9k | $1.90 | $414k | See footnote | 08/16/2022 |
08/16/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 1.3M | $1.90 | $2.6M | See footnote | 08/16/2022 |
08/16/2022 | IN8BIO, INC. | INAB | Purchase | Common Stock | 206.6k | $1.90 | $392.5k | See footnote | 08/16/2022 |
03/17/2022 | Lantern Pharma Inc. | LTRN | Exercise (in-the-money or at-the-money) | Common Stock | 60.4k | $189,152.16 | $11430.8M | Bios Fund I, LP | 03/17/2022 |
03/17/2022 | Lantern Pharma Inc. | LTRN | Exercise (in-the-money or at-the-money) | Common Stock | 35.3k | $110,636.11 | $3910.7M | Bios Fund I QP, LP | 03/17/2022 |
03/17/2022 | Lantern Pharma Inc. | LTRN | Exercise (in-the-money or at-the-money) | Series A Warrants | 60.4k | $0.00 | $0 | Bios Fund I, LP | 03/17/2022 |
03/17/2022 | Lantern Pharma Inc. | LTRN | Exercise (in-the-money or at-the-money) | Series A Warrants | 35.3k | $0.00 | $0 | Bios Fund I QP, LP | 03/17/2022 |
|
|